QLT USA, INC.
Patent Owner
Stats
- 3 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Apr 03, 2014 most recent publication
Details
- 3 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 622 Total Citation Count
- Sep 27, 1994 Earliest Filing
- 11 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2014/0094,484 SUSTAINED DELIVERY FORMULATIONS OF RAPAMYCIN COMPOUNDSAbandonedOct 02, 12Apr 03, 14[A61K, A61P]
2009/0092,650 Sustained Delivery Formulations of Octreotide CompoundsAbandonedDec 15, 05Apr 09, 09[A61K, A61P]
2007/0142,317 Topical composition for treatment of skin disordersAbandonedJun 29, 06Jun 21, 07[A61K]
2007/0104,759 Polymeric delivery formulations of leuprolide with improved efficacyAbandonedDec 21, 06May 10, 07[A61K, A61F]
2006/0121,085 Formulations for cell-schedule dependent anticancer agentsAbandonedSep 09, 05Jun 08, 06[A61K, A61F]
2006/0078,599 Pharmaceutical composition applicable to body tissueAbandonedOct 12, 04Apr 13, 06[A61K]
2004/0229,912 Polymeric delivery formulations of leuprolide with improved efficacyAbandonedJun 21, 04Nov 18, 04[A61K]
5762917 Method and composition for cleansing wounds with minimal cytotoxicity for minimal scarringExpiredMar 26, 96Jun 09, 98[A61K]
5631301 Topical antibiotic composition providing optimal moisture environmentExpiredSep 27, 94May 20, 97[A61K]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.